Psoriasiform drug eruption due to glibenclamide.
D001623:Betamethasone / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000473:pathology*
D001623:Betamethasone; D005905:Glyburide